San Clemente, Calif., April 10th, 2019--(BUSINESS WIRE)-- Reflow Medical, Inc. has announced the completion of enrollment in its Wing-IT investigational device exemption trial, a prospective, multicenter, nonrandomized study evaluating the…
Dr. Jihad Mustapha of Grand Rapids, Michigan, explains how the Spur device, a spiked self-expanding stent is intended for use in conjunction with a drug-coated balloon, can help drug delivery…
Dr. Mathews, Director of the Cardiac Catheterization Laboratory at Manatee Memorial Hospital in Bradenton, Florida, joined Reflow Medical, Inc. at the conclusion of the Transcatheter Cardiovascular Therapeutics (TCT) symposium held…
Non-Randomized Study Evaluating the Use of the Reflow Medical Wingman Catheter to Cross Chronic Total Occlusions in Infrainguinal Peripheral ArTeries) SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical Inc., a developer of innovative medical devices…
SAN CLEMENTE, Calif.--(BUSINESS WIRE)— Reflow Medical, Inc., a developer and innovator of crossing and support catheters for use in the treatment of occlusive cardiovascular disease, announced that the company has…
San Clemente, Calif.–(BUSINESS WIRE)—ReFlow Medical Inc. announced the issuance of U.S. Patent No. 9,204,893 entitled, “Systems, Methods, and Devices for Ablation, Crossing, and Cutting of Occlusions” for its innovative Wingman…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)—ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their speX™ Shapeable Support Catheter for use in the peripheral vasculature as well as the first…
(L) John R. Laird, Jr., MD, is an Interventional Cardiology and Cardiology specialist in St. Helena, CA. (R) Mahmood K. Razavi, MD, specializes in Radiology, Vascular and Interventional Radiology in…
Recent Comments